Clearmind Medicine Inc. financial data

Symbol
CMND on Nasdaq
Industry
Pharmaceutical Preparations
Location
101 1220 West 6 Th Avenue, Vancouver, British Columbia, Canada (Federal Level)
State of incorporation
Canada (Federal Level)
Fiscal year end
October 31
Latest financial report
20-F - Q3 2024 - Jan 22, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.27M shares +602%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense 1.38M USD -10.5%
General And Administrative Expense 4.36M USD -8.34%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets 7.26M USD +21.9%
Liabilities 4.15M USD -16.5%